EMA Says Possible Link Of Pfizer, Moderna Vaccines To Rare Myocarditis, Pericarditis
T-Reuters2021-07-09
- Europe's drug regulator has found a probable link between heart inflammation and COVID-19 vaccines made by Pfizer(NYSE:PFE)and Moderna(NASDAQ:MRNA),Reuters reports.
- Heart conditions myocarditis and pericarditis must be listed as possible side effects of the two mRNA vaccines, the EMA said.
- This included an in-depth review of 145 cases of myocarditis and 138 cases of pericarditis in Europe among people who received BioNTech's(NASDAQ:BNTX)Comirnaty and 19 cases in those who received Moderna's Spikevax.
- The EMA panel has also advised people with a history of a rare blood disorder should avoid Johnson & Johnson'(NYSE:JNJ)single-shot coronavirus vaccine.
- Three cases of capillary leak syndrome(CLS) were reviewed who had received J&J shot. One of those affected had a history of CLS and two of them subsequently died.
- Last month, U.S. health officials reported possible link betweenheart inflammation condition and mRNA-based COVID-19 shots.
- Earlier in June, the EMA asked CLS to be added as aside effect from AstraZeneca's(NASDAQ:AZN) jab.
免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。